In the relentless pursuit of effective treatments for viral infections, pharmaceutical intermediates play a pivotal role. One such critical compound is Dasabuvir, identified by its CAS number 1132935-63-7 and commonly referred to as ABT-333. As a white powder with exceptional purity exceeding 99%, Dasabuvir (ABT-333) stands as a cornerstone in the synthesis of advanced antiviral medications. Its primary significance lies in its potent activity against the Hepatitis C virus (HCV), specifically targeting the viral RNA-dependent RNA polymerase, a key enzyme essential for viral replication. This makes it an indispensable component for pharmaceutical companies engaged in the research and development of novel therapies.

NINGBO INNO PHARMCHEM CO.,LTD. recognizes the critical importance of high-purity pharmaceutical intermediates like Dasabuvir (ABT-333) in advancing global health. Our commitment as a reliable supplier in China ensures that researchers and manufacturers have access to this vital compound. The molecular structure and formula of Dasabuvir (ABT-333) are meticulously managed to meet the stringent requirements of the pharmaceutical industry. By providing a consistent supply of this high-purity intermediate, we aim to support breakthroughs in antiviral drug discovery and contribute to better patient outcomes. The price and availability of such critical research chemicals are managed to facilitate the progression of vital medical research.

The journey from a chemical intermediate to a life-saving drug is complex, involving rigorous testing and development. Dasabuvir (ABT-333) serves as a foundational element in this process, enabling the creation of more effective and targeted antiviral treatments. Understanding the precise molecular weights and chemical properties of such compounds is paramount for successful synthesis and formulation. As NINGBO INNO PHARMCHEM CO.,LTD., we are dedicated to upholding the highest standards of quality and reliability, ensuring that our clients can confidently integrate Dasabuvir (ABT-333) into their pharmaceutical synthesis and research endeavors. Our role as a manufacturer in China is to facilitate the global availability of essential pharmaceutical building blocks.